ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

CAPSTONE INVESTMENT ADVISORS, LLC's Holding History (CIK: 0001426196)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 7,500,000 Value ($000) $8,655 Avg Close — Range —
Q4 2024
Shares 7,500,000 Value ($000) $7,991 Avg Close — Range —
Q3 2024
Shares 7,500,000 Value ($000) $8,786 Avg Close — Range —
Q2 2024
Shares 7,500,000 Value ($000) $8,100 Avg Close — Range —
Q1 2024
Shares 12,500,000 Value ($000) $11,811 Avg Close — Range —
Q4 2023
Shares 17,500,000 Value ($000) $17,281 Avg Close — Range —
Q3 2023
Shares 10,000,000 Value ($000) $9,275 Avg Close — Range —